Press Release FeedGet the RSS feed
Menu

Business Wire

IQM Quantum Computers Announces Conference Call to Report Third Quarter 2026 Financial Results on November 5, 2026

Business Wire

ESPOO, Finland, October 22, 2026--As published previously, IQM Quantum Computers Plc (Nasdaq: IQMX) ("IQM" or the "Company"), a global leader in superconducting quantum computers, will report financial results for the third quarter 2026 on Thursday, November 5, 2026. CEO Dr. Jan Goetz and CFO Jan Kuerschner will host a conference call at 3:00 PM EET / 2:00 PM CET / 8:00 AM EST on the same day followed by a Q&A session with analysts.

Conference Call and Webcast

A live audio webcast of the conference call will be available to the public through the link below and can be accessed in the News & Events section of IQM's Investor Relations website at https://investors.iqm.tech/. A replay of the call will be available at the same location for one year following the call. Participation in the Q&A during the conference call will require registration using the link below.

  • Date: Thursday, November 5, 2026

  • Time: 3:00 PM EET / 2:00 PM CET / 8:00 AM EST

  • Webcast Link: https://edge.media-server.com/mmc/p/syqjnhp6

  • To ask questions on the conference call, please register using the following link: https://register-conf.media-server.com/register/BIb52a4b5f4c064365b9adb306ffbb5420

About IQM Quantum Computers

IQM Quantum Computers (Nasdaq: IQMX) is a global leader in superconducting quantum computers, delivering full-stack quantum computers and cloud platform access to enterprises, research institutions, universities, high-performance computing centers, and national laboratories worldwide. IQM's on-premises deployment model gives customers direct ownership and control of their quantum infrastructure. Founded in 2018 and headquartered in Finland, with major operations in Munich, IQM employs over 450 people and operates across Europe, Asia, and North America. IQM is the first publicly listed European quantum company on the Nasdaq Stock Market.

View source version on businesswire.com: https://www.businesswire.com/news/home/20261021631977/en/

Contacts

Investor contact:
Henrik Klobut, Investor Relations
[email protected]

Media contact:
[email protected]

  1. Biotech & pharmaFerrer and Prilenia Announce Authorization for EU Initiation of Confirmatory PRECISE-HD Study of Pridopidine in Huntington's DiseaseBARCELONA, Spain, October 22, 2026--Ferrer i and Prilenia Therapeutics B.V. today announced that the confirmatory Phase 3 PRECISE-HD study of investigational pridopidine in Huntington's disease (HD) has received authorization to begin in participating EU Member States (EU CT number: 2026-526093-16-00,
  2. RhymeQ Raises $2.2 Million to Make Coding for Quantum Computers Easy for Millions of Developers WorldwideRhymeQ has developed Rhyme, a product that makes programming quantum computers as simple as writing in Python Launching at NVIDIA GTC Berlin, built on NVIDIA CUDA-Q Round led by Ground State Ventures with participation from Vanagon Ventures, Plug and Play, and Freiraum Ventures. BERLIN, October 22, 2026 --( BUSINESS WIRE
  3. AutomotiveEOS Defence SystemsEOS and VOP CZ Sign Memorandum of Understanding to Explore Cooperation on Czech ProgrammesVOP CZ's TAROS is an autonomous and remote-controlled robotic ground vehicle designed for military logistics and support missions The Bushmaster Protected Mobility Vehicle (PMV) is a 4x4 armored infantry mobility vehicle designed by Thales Defence Australia, with licenced production to VOP CZ PRAGUE, October 22, 2026 --(
  4. AIBlack HatBlack Hat Europe Returns to the Excel London with Briefings, Summits, and Trainings Confronting Today's Most Urgent Cyber ThreatsKey themes driving this year's lineup are AI & Autonomous Threats; Cyber Conflict & Live Operations; Systems Under Stress; and Identity, Trust, & Control LONDON, October 22, 2026--Black Hat , the cybersecurity industry's most established and in-depth security event series, today announced the release
  5. Maurel & Prom: Activity for the First Nine Months of 2026PARIS, October 22, 2026--Regulatory News: Maurel & Prom (Paris:MAU): M&P working interest production for the first nine months of 2026: 39,126 boepd, up 4% compared with 2025, with an acceleration in Q3 (+8% versus Q2) M&P working interest production of 13,710 bopd in Gabon M&P working interest product
  6. SportsNFL Biosciences Receives Regulatory Approval to Begin Its Phase 2 TONIC Trial for Smoking and Nicotine CessationThe TONIC Phase 2 trial evaluating NFL-102 consists of Part A (the first 40 participants) and Part B (the next 270 participants) Enrollment of the first participants (Part A) is scheduled to begin in November 2026 Analysis and communication of the results from Part A expected in April 2027 MONTPELLIER, France, October 22,